Skip to main content
. 2023 Apr 28;3(3):oead045. doi: 10.1093/ehjopen/oead045

Table 1.

Baseline characteristics

All (n = 542) LA strain ≤ 27.2% (n = 271) LA strain > 27.2% (n = 271) P-value
Clinical
 Age, mean (SD) 67.3 (8.88) 68.07 (9.08) 66.53 (8.62) 0.043
 Female sex, n (%) 89 (16.4%) 45 (16.6%) 44 (16.2%) 0.91
 EuroSCORE II, median (IQR) 1.31 (0.93–1.96) 1.49 (1.05–2.43) 1.19 (0.88–1.67) <0.001
 Hypertension, n (%) 364 (67.2%) 187 (69%) 177 (65.3%) 0.36
 Heart rate, mean (SD) 69.59 (13.14) 69.44 (13.67) 69.73 (12.62) 0.80
 Diabetes, n (%) 133 (24.5%) 78 (28.8%) 55 (20.3%) 0.022
 BMI, mean (SD) 26.95 (3.74) 27.08 (3.66) 26.82 (3.82) 0.42
 Smoking status, n (%) 0.85
  Current 117 (21.6%) 56 (20.7%) 61 (22.5%)
  Never 267 (49.3%) 134 (49.4%) 133 (49.1%)
  Former 158 (29.2%) 81 (29.9%) 77 (28.4%)
 Chronic obstructive lung disease, n (%) 34 (6.3%) 16 (5.9%) 18 (6.6%) 0.72
 Prior AMI, n (%) 128 (23.7%) 72 (26.6%) 56 (20.7%) 0.11
 Prior stroke, n (%) 52 (9.6%) 32 (11.8%) 20 (7.4%) 0.080
 CABG indication, n (%) 0.096
  Stable angina pectoris 271 (50%) 123 (45.4%) 148 (54.6%)
  Acute coronary syndrome 271 (50%) 148 (54.6%) 123 (45.4%)
Biochemistry
 C reactive protein (mg/L), median (IQR) 4 (2–9) 5 (2–10) 2 (2–8) 0.013
 eGFR (mL/min/1.73m2), mean (SD) 71.86 (18.6) 69.91 (18.61) 73.82 (18.42) 0.014
Echocardiography
 GLS %, mean (SD) −13.48 (3.96) −12.51 (3.91) −14.46 (3.78) <0.001
 LVEF biplane, mean (SD) 50.57 (11.02) 47.78 (12.2) 53.35 (8.9) <0.001
 E/e’, median (IQR) 10.07 (8.18–12.62) 10.72 (8.8–13.88) 9.45 (7.84–11.73) <0.001
 LAVi (mL/m2), mean (SD) 23.66 (8.32) 25.9 (9.13) 21.42 (6.74) <0.001

BMI, body mass index; AMI, acute myocardial infarction; CABG, coronary artery bypass grafting; eGFR, estimated glomerular filtration rate; GLS, global longitudinal strain; LVEF, left ventricular ejection fraction; E/e´, ratio of early transmitral inflow velocity to early myocardial relaxation velocity; LAVi, left atrial volume index; SD, standard deviation.